Effect of anti-LFA1 (CDlla) monoclonal antibodies in acute rejection in human kidney transplantation

Transplantation

Volumn 52, Issue 2, 1991, Pages 291-296

  Mauff, Brigitte Le ^a,b   Hourmant, Maryvonne ^a   Rougier, Jean Philippe ^a,b   Hirn, Michel ^c   Dantal, Jacques ^a   Baatard, Remy ^a   Cantarovich, Diego ^a   Jacques, Yannick ^b   Soulillou, J P ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LYMPHOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MIDDLE AGE; PILOT PROJECTS; SUPPORT, NON-U.S. GOV'T;

EID: 0025916337     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199108000-00020     Document Type: Article

References (29)

1. Kürzinger K, Reynolds T, Germain RN, Davignon D, Martz E, Springer TA. A novel lymphocyte function-associated antigen (LFA1): cellular distribution, quantitative expression, and structure. J Immunol 1981; 127: 596.
2. Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA. A human leukocyte differentiation antigen family with distinct a-subunits and a common β-subunit: the lymphocyte function- associated antigen (LFA1), the C3bi complement receptor (OKMl/Mac-1), and the pl50, 95 molecule. J Exp Med 1983; 158: 1785.
3. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function associated LFA1, CD2 and LFA3 molecules: cell adhesion receptors of the immune system. Ann Rev Immunol 1987; 5: 223.
4. Lo SK, van Seventer GA, Levin SM, Wright SD. Two leukocyte receptors (CDlla/CD18 and CDllb/CD18) mediate transient adhesion to endothelium by binding to different ligands. J Im-munol 1989; 143: 3325.
5. Sanders VM, Snyder JM, Uhr JW, Vitetta ES. Characterization of the physical interaction between antigen-specific B and T cells. J Immunol 1986; 137: 2395.
6. Mentzer SJ, Gromkowski SH, Krensky AM, Burakoff SJ, Martz E. LFA1 membrane molecule in the regulation of homotypic adhesions of human B lymphocytes. J Immunol 1985; 135: 9.
7. Davignon D, Martz E, Reynolds T, Kiirzinger K, Springer TA. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA1): mechanism of blockade of T lymphocyte-me-diated killing and effects on other T and B lymphocyte functions. J Immunol 1981; 127: 590.
8. Wacholtz MC, Patel SS, Lipsky PE. Leukocyte function-associated antigen 1 is an activation molecule for human T cells. J Exp Med 1989; 170: 431.
9. Pardi R, Bender JR, Dettori C, Giannazza E, Engleman EG. Heterogenous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA1) in human lymphocyte subsets. J Immunol 1989; 143: 3157.
10. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA1). Cell 1987; 51: 813.
11. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA1 homologous to ICAM- 1. Nature 1989; 339: 61.
12. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL1 and interferon-7: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245.
13. Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137:1893.
14. Buckle AM, Hogg N. Human memory T cells express intercellular adhesion molecule I which can be increased by interleukin 2 and interferon gamma. Eur J Immunol 1990; 20: 337.
15. Fisher A, Griscelli C, Blanche S, et al. Prevention of graft failure by an anti-LFAl monoclonal antibody in HLA-mismatched bone marrow transplantation. Lancet 1986; 2: 1058.
16. Perez N, Le Deist F, Chatenoud L, Chanteloup N, Griscelli C, Fisher A. In vivo infusion of anti LFA1 antibody in HLA nonidentical bone marrow transplantation in children: serum concentrations and biological effects. Bone Marrow Transplantation 1989; 4: 379.
17. Baume D, Kuentz M, Pico JL, et al. Failure of a CD18/anti-LFAl monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T depleted allogeneic bone marrow transplantation. Transplantation 1989; 47: 472.
18. Cosimi AB, Geoffrion C, Anderson T, Conti D, Rothlein R, Colvin RB. Immunosuppression of cynomolgus recipients of renal allografts by R6.5, a monoclonal antibody to intercellular adhesion molecule-1. In: Springer TA, Anderson DC, Rosenthal AS, Rothlein R, eds. Leukocyte adhesion molecules. New York: Springer, 1988: 274.
19. Dougherty GJ, Hogg N. The role of monocyte lymphocyte function-associated antigen I (LFA1) in accessory cell function. Eur J Immunol 1987; 17: 943.
20. Dougherty GJ, Murdoch S, Hogg N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 1988; 18: 35.
21. Soulillou JP, Cantarovich D, Le Mauff B, et al. Randomized trial of an anti-interleukin 2 receptor monoclonal antibody (33B3.1) versus rabbit antithymocyte globulin (ATG) in prophylaxis of early rejection in human renal transplantation. N Engl J Med 1990; 322:1175.
22. Maraninchi D, Mawas C, Reiffers J, et al. Anti LFA1 monoclonal antibody and bone marrow graft rejection in adults. Lancet 1988; 2: 579.
23. Cantarovich D, Le Mauff B, Hourmant M, et al. Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft: a pilot study. Transplantation 1989; 47: 454.
24. Soulillou JP, Peyronnet P, Le Mauff B, et al. Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2 receptor. Lancet 1987; 1:1339.
25. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution and structure of LFA1, LFA2 and LFA3: cell surface antigens associated with CTL-target interactions. J Immunol 1983; 131: 611.
26. Goldstein G, Fuccello AJ, Norman DI, Shield CF III, Colvin RB, Cosimi AB. OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3. Transplantation 1986; 42: 507.
27. Fischer A, Durandy A, Sterkers G, Griscelli C. Role of the LFA1 molecule in cellular interactions required for antibody production in humans. J Immunol 1986; 136: 3198.
28. Benjamin RJ, Qin S, Wise MP, Cobbold SP, Waldmann H. Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CDlla (LFA1) molecules in self-non-self discrimination. Eur J Immunol 1988; 18: 1079.
29. Benjamin RJ, Cobbold SP, Clark MR, Waldmann H. Tolerance to rat monoclonal antibodies. J Exp Med 1986; 163: 1539